Objective: The pathogenesis of idiopathic sudden sensorineural hearing loss (ISSHL) remains unknown, but vascular involvement is one of the main hypotheses. The main objective of this study was to investigate the association between ISSHL and cardiovascular and thromboembolic risk factors. Study Design: Multicentric case-control study. Methods: Ninety-six Caucasian patients with ISSHL and 179 sex- and age-matched controls were included. Patients were evaluated on the day of the inclusion and 1 week, 3 weeks and 3 months later. Clinical information concerning personal and familial cardiovascular and thromboembolic risk factors and concerning the ISSHL was collected. Blood samples were collected for genetic analysis of factor V Leiden and G20210A polymorphism in the factor II gene. The severity of the hearing loss was classified as mild (21–40 dB), moderate (41–70 dB), severe (71–90 dB) and profound or total (>90 dB). Hearing improvement was calculated as a relative improvement of hearing thresholds using the contralateral ear as baseline. Results: Systolic blood pressure was higher in patients (130 ± 1.7 mm Hg) than in controls (124 ± 1.1 mm Hg, p = 0.003). The personal/familial history of cardiovascular events was also more prevalent in patients (p = 0.023 and p = 0.014, respectively), whereas no difference was found in the prevalence of personal cardiovascular risk factors (hypertension, diabetes mellitus, hyperlipidemia, smoking habits). There was no correlation between the audiogram type, the hearing outcome and the presence of cardiovascular risk factors. No significant difference was observed in the personal/familial history or in the presence of thromboembolic risk factors. The prothrombin and factor V mutations were uncommon in both patients and controls. The final hearing threshold was only correlated with the severity of the initial hearing loss (p < 0.001), but not influenced by the presence of vertigo, audiogram type, time elapsed from onset of ISSHL to hospitalization or failure of a previous oral therapy. Hearing stabilization was obtained at 21 days in 92% of patients. Conclusion: These results support the theory of vascular involvement as the etiology of some cases of ISSHL. The sole predictive factor of poor final hearing is the severity of the initial hearing loss.

Keywords:
Idiopathic sudden sensorineural hearing loss, Cardiovascular risk factors, Thromboembolic risk factors
1.
Ameziane N, Lamotte M, Lamoril J, Lebret D, Deybach JC, Kaiser T, de Prost D: Combined factor V leiden (G1691A) and prothrombin (G20210A) genotyping by multiplex real-time polymerase chain reaction using fluorescent resonance energy transfer hybridization probes on the Rotor-Gene 2000. Blood Coagul Fibrinolysis 2003;14:421–424.
2.
Ballesteros F, Alobid I, Tassies D, Reverter JC, Scharf RE, Guilemany JM, Bernal-Sprekelsen M: Is there an overlap between sudden sensorineural hearing loss and cardiovascular risk factors? Audiol Neurotol 2009;14:139–145.
3.
Byl FM: Sudden hearing loss: eight years’ experience and suggested prognostic table. Laryngoscope 1984;94:647–661.
4.
Cadoni G, Scipione S, Rocca B, Agostino S, La Greca C, Bonvissuto D, Paludetti G: Lack of association between inherited thrombophilic risk factors and idiopathic sudden sensorineural hearing loss in Italian patients. Ann Otol Rhinol Laryngol 2006;115:195–200.
5.
Capaccio P, Ottaviani F, Cuccarini V, Bottero A, Schindler A, Cessana BM, Censuales S, Pignataro L: Genetic and acquired prothrombotic risk factors and sudden hearing loss. Laryngoscope 2007;117:547–551.
6.
Ceylan A, Celenk F, Kemaloglu YK, Bayazit YA, Göksu N, Ozbilen S: Impact of prognostic factors on recovery from sudden hearing loss. J Laryngol Otol 2007;121:1035–1040.
7.
Chang NC, Ho KY, Kuo WR: Audiometric patterns and prognosis in sudden sensorineural hearing loss in southern Taiwan. Otolaryngol Head Neck Surg 2005;133:916–922.
8.
Ciuffetti G, Scardazza A, Serafini G, Lombardini R, Mannarino E, Simoncelle C: Whole-blood filterability in sudden deafness. Laryngoscope 1991;101:65–67.
9.
Conlin AE, Parnes LS: Treatment of sudden sensorineural hearing loss. Arch Otolaryngol Head Neck Surg 2007;133:573–586.
10.
Fetterman BL, Saunders JE, Luxford WM: Prognosis and treatment of sudden sensorineural hearing loss. Am J Otol 1996;17:529–536.
11.
Germain DP, Avan P, Chassaing A, Bonfils P: Patients affected with Fabry disease have an increased incidence of progressive hearing loss and sudden deafness: an investigation of 22 hemizygous male patients. BMC Med Genet 2002;3:10.
12.
Görür K, Tuncer U, Eskandari G, Özcan C, Ünal M, Özsahinoglu C: The role of factor V Leiden and prothrombin G20210a mutations in sudden sensorineural hearing loss. Otol Neurotol 2005;26:599–601.
13.
Grgic M, Petric V, Grgic MP, Demarin V, Pegan B: Doppler ultrasonography of the vertebrobasilar circulation in patients with sudden sensorineural hearing loss. J Otolaryngol 2005;34:51–59.
14.
Hirano K, Ikeda K, Kawase T, Oshima T, Kekehata S, Takahashi S, Sato T, Kobayashi T, Takasaka T: Prognosis of sudden deafness with special reference to risk factors of microvascular pathology. Auris Nasus Larynx 1999;26:111–115.
15.
Hoshijima H, Makimoto K, Noi O, Ohinata Y, Takenaka H: Effect of nitric oxide synthase inhibitor on cochlear blood flow. Hear Res 2002;171:32–42.
16.
Lee H and Baloh RW: Sudden deafness in vertebrobasilar ischemia: clinical features, vascular topographical patterns and long-term outcome. J Neurol Sci 2005;228:99–104.
17.
Lin HC, Chao PZ, Lee HC: Sudden sensorineural hearing loss increases the risk of stroke. A 5-year follow-up study. Stroke 2008;39:2744–2748.
18.
Lu YY, Jin Z, Tong BS, Yang JM, Liu YH, Duan M: A clinical study of microcirculatory disturbance in Chinese patients with sudden deafness. Acta Otolaryngol 2008;128:1168–1172.
19.
Mannini L, Cecchi E, Fatini C, Marcucci R, Liotta AA, Matucci-Cerinic M, Abbate R, Gensini GF: Clinical haemorheology and microcirculation. Ann Ist Super Sanita 2007;43:144–155.
20.
Marcucci R, Alesssandrello Liotta A, Cellai AP, Rogolino A, Berloco P, Leprini E, Pagnini P, Abbate R, Prisco D: Cardiovascular and thrombophilic risk factors for idiopathic sudden sensorineural hearing loss. J Thromb Haemost 2005;3:929–934.
21.
Maresca G, Di Blasio A, Marchioli R, Di Minno G: Measuring plasma fibrinogen to predict stroke and myocardial infarction: an update. Arterioscler Thromb Vasc Biol 1999;19:1368–1377.
22.
Mercier E, Quere I, Chabert R, Lallemant JG, Daures JP, Berlan J, Gris JP: The 20210A allele of the prothrombin gene is an independent risk factor for perception deafness in patients with venous thromboembolic antecedents. Blood 1999;93:3150–3152.
23.
Mom T, Avan P, Romand R, Gilain L: Monitoring of functional changes after transient ischemia in gerbil cochlea. Brain Res 1997;751:20–30.
24.
Mom T, Gilain L, Avan P: Cochlear ischemia: from fundamental data to clinical hope. Ann Otolaryngol Chir Cervicofac 2008;125:301–308.
25.
Moon IS, Kim J, Lee SY, Choi HS, Lee WS: How long should the sudden hearing loss patients be followed after early steroid combination therapy? Eur Arch Otorhinolaryngol 2009;266:1391–1395.
26.
Mosnier I, Bouccara D, Sterkers O: Management of idiopathic sudden sensorineural hearing loss. Otolaryngol Nova 1999;9:217–223.
27.
Nakashima T, Tanabe T, Yanagita N, Wakai K, Ohno Y: Risk factors for sudden deafness: a case-control study. Auris Nasus Larynx 1997;24:265–270.
28.
Ohinata Y, Makimoto K, Kawakami M, Haginomori S, Araki M, Takahashi H: Blood viscosity and plasma viscosity in patients with sudden deafness. Acta Otolaryngol (Stockh) 1994;114:601–607.
29.
Orita S, Fukushima K, Orita Y, Nishizaki K: Sudden hearing impairment combined with diabetes mellitus or hyperlipidemia. Eur Arch Otorhinolaryngol 2007;264:359–362.
30.
Patscheke JH, Arndt J, Dietz K, Zenner HP, Reuner KH: The prothrombin G20210A mutation is a risk factor for sudden hearing loss in young patients. Thromb Heamost 2001;86:1118–1119.
31.
Plontke S, Bauer M, Meisner C: Comparison of pure-tone audiometry analysis in sudden hearing loss studies: lack of agreement for different outcome measures. Otol Neurotol 2007;28:753–763.
32.
Ren T, Brown NJ, Zhang M, Nutall AL, Miller JM: A reversible ischemia model in gerbil cochlea. Hear Res 1995;92:30–37.
33.
Rudack C, Langer C, Junker R: Platelet GPIaC807T polymorphism is associated with negative outcome of sudden hearing loss. Hear Res 2004;191:41–48.
34.
Rudack C, Langer C, Stoll W, Rust S, Walter M: Vascular risk factors in sudden hearing loss. Thromb Haemost 2006;95:454–461.
35.
Suckfüll M: Fibrinogen and LDL apheresis in treatment of sudden hearing loss: a randomised multicentre trial. Lancet 2002;360:1811–1817.
36.
Suckfüll M, Wimmer C, Reichel O, Mees K, Schorn K: Hyperfibrinogenemia as a risk factor for sudden hearing loss. Otol Neurotol 2002;23:309–311.
37.
Suzuki K, Kaneko M, Murai K: Influence of serum lipids on auditory function. Laryngoscope 2000;110:1736–1738.
38.
Tange RA: Vascular inner ear partition: a concept for some forms of sensorineural hearing loss and vertigo. ORL J Otorhinolaryngol Relat Spec 1998;60:78–94.
39.
Tran Ba Huy P: Idiopathic sudden sensorineural hearing loss. Otorhinolaryngol Nova 1999;9:171–177.
40.
Tran Ba Huy P, Sauvaget E: Idiopathic sudden sensorineural hearing loss is not an otologic emergency. Otol Neurotol 2005;26:896–902.
41.
Ulrich D, Aurbach G, Drobik C: A prospective study of hyperlipidemia as a pathogenic factor in sudden hearing loss. Eur Arch Otorhinolaryngol 1992;249:273–276.
42.
Wangemann P, Wonneberger K: Neurogenic regulation of cochlear blood flow occurs along the basilar artery, the anterior inferior cerebellar artery and at branch points of the spiral modiolar artery. Hear Res 2005;209:91–96.
43.
Yamasoba T, Kikuchi S, Higo R, O’Uchi T, Tokumaru A: Sudden sensorineural hearing loss associated with slow blood flow of the vertebrobasilar system. Ann Otol Rhinol Laryngol 1993;102:873–877.
44.
Yeo SW, Lee DH, Jun BC, Park SY, Park YS: Hearing outcome of sudden sensorineural hearing loss: long-term follow-up. Otolaryngol Head Neck Surg 2007;136:221–224.
45.
Yildiz Z, Ulu A, Incesulu A, Ozkaptan Y, Akar N: The importance of thrombotic risk factors in the development of idiopathic sudden hearing loss. Clin Appl Thromb Hemost 2008;14:356–359.
© 2010 S. Karger AG, Basel
2010
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.